Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort

Rahela Aziz-Bose1,2,3,4, Colin Cernik1, Puja J Umaretiya5

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Pediatric Blood & Cancer
|August 12, 2024
PubMed

Insights

Poverty-exposed children with cancer face worse outcomes. Increasing participation in the Supplemental Nutrition Assistance Program (SNAP) during treatment can help reduce these health disparities.

Area of Science:

  • Pediatric Oncology
  • Public Health Nutrition
  • Health Disparities Research

Background:

  • Children with cancer from low-income backgrounds experience poorer health outcomes.
  • The Supplemental Nutrition Assistance Program (SNAP) can improve food security and child health.
  • SNAP may help mitigate health disparities in pediatric cancer patients.

Purpose of the Study:

  • To assess the eligibility and participation rates of families with children undergoing leukemia treatment in the Supplemental Nutrition Assistance Program (SNAP).
  • To identify opportunities for interventions to increase SNAP participation among vulnerable pediatric cancer populations.

Main Methods:

  • Secondary analysis of parent-reported data from a frontline pediatric leukemia clinical trial (NCT03020030).
  • SNAP eligibility was proxied by participation in other means-tested programs.
  • Data analyzed at diagnosis and at 6 months post-diagnosis.

Main Results:

  • At diagnosis, 37% of families were SNAP-eligible, with 50% participation among eligible families.
  • At 6 months, 41% of families were SNAP-eligible, with 57% participation.
  • A significant proportion of eligible families were not participating in SNAP during childhood cancer treatment.

Conclusions:

  • Interventions to boost SNAP participation during childhood cancer treatment are crucial.
  • Increasing access to nutrition assistance can help reduce cancer-related health disparities.
  • Addressing food insecurity is a key strategy for improving outcomes in pediatric cancer patients.